Brain gene therapy tested for Parkinson's – early results in
Disease control
Completed
This early-stage trial tested a gene therapy for Parkinson's disease. The treatment involved delivering a gene called GAD into a brain region that controls movement. Only 14 people took part, and the main goal was to check safety, not whether it works. The study is now complete.
Phase: PHASE1, PHASE2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Jun 26, 2026 14:07 UTC